Prelude Therapeutics Inc (NASDAQ: PRLD) is 21.78% higher on its value in year-to-date trading and has touched a low of $1.66 and a high of $6.80 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The PRLD stock was last observed hovering at around $5.20 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $5.20, the stock is -3.92% and 4.37% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.2 million and changing 0.00% at the moment leaves the stock 24.61% off its SMA200. PRLD registered 35.77% gain for a year compared to 6-month gain of 13.29%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -7.96% loss in the last 1 month and extending the period to 3 months gives it a 35.06%, and is -3.17% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.97% over the week and 13.30% over the month.
Prelude Therapeutics Inc (PRLD) has around 128 employees, a market worth around $286.10M and $0.00M in sales. Distance from 52-week low is 213.25% and -23.53% from its 52-week high. The company has generated returns on investments over the last 12 months (-65.67%).
The EPS is expected to grow by 9.31% this year.
Prelude Therapeutics Inc (PRLD) Top Institutional Holders
91.0 institutions hold shares in Prelude Therapeutics Inc (PRLD), with institutional investors hold 103.48% of the company’s shares. The shares outstanding are 42.06M, and float is at 21.18M with Short Float at 6.77%. Institutions hold 94.10% of the Float.
The top institutional shareholder in the company is ORBIMED ADVISORS LLC with over 10.91 million shares valued at $41.56 million. The investor’s holdings represent 14.4043% of the PRLD Shares outstanding. As of 2024-06-30, the second largest holder is BAKER BROS. ADVISORS LP with 10.12 million shares valued at $$38.57 million to account for 13.3673 of the shares outstanding. The other top investors are DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) which holds 4.13 million shares representing 5.4571% and valued at over $15.75 million, while BOXER CAPITAL, LLC holds 3.3911 of the shares totaling 2.57 million with a market value of $9.79 million.
Prelude Therapeutics Inc (PRLD) Insider Activity
#####
